ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,001Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 113

$462K Total Retail Price of All Prescriptions

Rank: 39 out of 113

510 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,189 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 890 819 1 2
LEVOTHYROXINE SODIUM 741 679 2 1
OMEPRAZOLE 511 488 3 5
LISINOPRIL 401 391 4 3
AMLODIPINE BESYLATE 330 313 5 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 290 264 6 34
CITALOPRAM HBR 275 241 7 17
POTASSIUM CHLORIDE 274 245 8 12
HYDROCHLOROTHIAZIDE 269 265 9 9
ALENDRONATE SODIUM 267 249 10 22
FUROSEMIDE 230 223 11 6
WARFARIN SODIUM 227 227 12 8
LOSARTAN POTASSIUM 212 206 13 13
ATORVASTATIN CALCIUM 211 200 14 15
METOPROLOL SUCCINATE 211 207 14 10
LOSARTAN-HYDROCHLOROTHIAZIDE 205 197 16 40
METFORMIN HCL 204 194 17 11
ALLOPURINOL 182 166 18 20
ATENOLOL 173 161 19 16
HYDROCODONE-ACETAMINOPHEN 147 123 S3 20 7
METOPROLOL TARTRATE 146 141 21 14
TAMSULOSIN HCL 144 128 22 24
DIGOXIN 138 138 23 27
ADVAIR DISKUS 119 113 24 35
GABAPENTIN 116 99 25 18
FLUOXETINE HCL 92 74 26 31
DONEPEZIL HCL 91 91 27 33
CRESTOR 89 88 28 30
SPIRONOLACTONE 86 86 29 32
FLUTICASONE PROPIONATE 82 76 30 39
PREDNISONE 78 74 31 28
TRIAMTERENE-HCTZ 77 77 32 26
KLOR-CON 10 77 76 32 68
GLYBURIDE 73 68 R 34 66
SERTRALINE HCL 71 60 35 21
PRAVASTATIN SODIUM 58 58 36 23
VENTOLIN HFA 57 54 37 110
ZOLPIDEM TARTRATE 56 49 38 19
LANTUS 55 54 39 38
VERAPAMIL ER 51 51 40 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.